| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 07/31/2003 | US20030143727 Continuous supply of both oxygen and nutrients to the cells are provided without directly exposing any cells to gas, reduces cell injury; intermittently submerging and emerging cells in growth medium; floating bag |
| 07/31/2003 | US20030143717 Peroxygen compound and an organic acid, composition having an acidic pH; for bird vaccines against coccidiosis |
| 07/31/2003 | US20030143716 Selection media for beauveriolide I or beauveriolide III and process for selectively producing these substances |
| 07/31/2003 | US20030143715 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203 |
| 07/31/2003 | US20030143711 Hydrolyses organophosphate insecticides including malathion; bioremediation |
| 07/31/2003 | US20030143710 Protein corresponding to recombinant fungal epoxide hydrolase; use making enantiomerically pure diols and/or epoxides |
| 07/31/2003 | US20030143707 Proteins having DNA repair promoting activity |
| 07/31/2003 | US20030143703 Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular PHA depolymerase |
| 07/31/2003 | US20030143700 Specific, asymmetric reduction of 3-quinuclidinone using tropinone reductase-I in the presence of a reduced coenzyme to produce (R)-3-quinuclidinol; high optical purity |
| 07/31/2003 | US20030143695 Novel polypeptide and dna thereof |
| 07/31/2003 | US20030143693 Growing, under suitable conditions, procaryotic or eucaryotic host cells transformed or transfected with a specific DNA, and isolating the desired polypeptide product of the expression of such DNA sequence |
| 07/31/2003 | US20030143691 Human testin |
| 07/31/2003 | US20030143690 Peptides and proteins that effect protein phosphorylation; genetic engineered DNA; useful for therapy and diagnosis |
| 07/31/2003 | US20030143685 Nucleic acid expression control sequence cassettes comprising a stable bacteriophage T5 promoter and nucleic acid regulatory sequences, useful for generating stable expressin vectors of high-level protein expression; culture product |
| 07/31/2003 | US20030143683 Introducing a nucleotide sequence encoding prefered amino acid sequences in into a host cell and culturing the host cell in which the peptides are expressed from the nucleotide sequence; human therapeutics and diagnostic protein |
| 07/31/2003 | US20030143680 Bacterial cells lacking deformylase and/or transformylase |
| 07/31/2003 | US20030143679 Genes encoding insect odorant receptors and uses thereof |
| 07/31/2003 | US20030143677 Activated rec-D-hydantoinases |
| 07/31/2003 | US20030143668 Guanosine triphosphate-binding protein coupled receptors |
| 07/31/2003 | US20030143667 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/31/2003 | US20030143666 Genetic locus for everninomicin biosynthesis |
| 07/31/2003 | US20030143665 Calcium independent receptor of alpha-latrotoxin,characterization and uses thereof |
| 07/31/2003 | US20030143660 Genes have been isolated from Rhodococcus and Deinococcus which encode a specific lycopene beta -cyclase capable of converting acyclic carotenoids with atleast one psi-end group to corresponding asymetric caratenoid |
| 07/31/2003 | US20030143659 Microbial biomass is granulated by extrusion and then dried to a dry matter content of atleast 80%, gives higher yields on extraction of the compound |
| 07/31/2003 | US20030143656 Drug screening compounds which inhibit rate of phosphorylation by kinase having hydrophobic pocket domain; surface plasmon resonance; fusion proteins; anticancer-/ antidiabetic agents |
| 07/31/2003 | US20030143654 Which participates in the ubiquitin-dependent proteolytic pathway that targets regulatory proteins for rapid intracellular degradation |
| 07/31/2003 | US20030143626 Such as cyclin-dependent kinases and/or bax genes/proteins covalently linked to platform compound (thioredoxin); drug screening |
| 07/31/2003 | US20030143623 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/31/2003 | US20030143622 Human RNA binding proteins |
| 07/31/2003 | US20030143621 Contacting a cellular component with a reagent which binds to PC-1 (prostate cancer-1) protein |
| 07/31/2003 | US20030143617 ATP synthase subunits |
| 07/31/2003 | US20030143611 Cloning the DNA sequence encoding recombinant SRTA-70 proteins |
| 07/31/2003 | US20030143595 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143588 Phosphodiesterases |
| 07/31/2003 | US20030143568 Methods and materials for characterizing and modulating interaction between heregulin and HER3 |
| 07/31/2003 | US20030143567 An expression vector containing a promoter operably linked to a nucleic acid that encodes a prokaryotic enzyme having both epimerase/ reductase activity catalyzes conversion of GDP-4-keto-6-deoxymannose to GDP-fucose |
| 07/31/2003 | US20030143564 A nucleic acid encodes the polypeptide or fragment has ability to form a triple helix, form higher order collagen fibrils or fibers and provide tensile strenght or flexibility to muscle connective tissue, recognized by R34 antibody |
| 07/31/2003 | US20030143563 Method for identifying a nucleic acid |
| 07/31/2003 | US20030143559 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
| 07/31/2003 | US20030143528 Vector for analayzing replication mechanism of rna virus and use thereof |
| 07/31/2003 | US20030143526 Recombinanr hhv8 dna |
| 07/31/2003 | US20030143522 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 07/31/2003 | US20030143248 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 07/31/2003 | US20030143246 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 07/31/2003 | US20030143245 Multivalent streptococcal vaccine compositions and methods for use |
| 07/31/2003 | US20030143244 For preparation of D-amino acids starting from 5'-substituted hydantoins |
| 07/31/2003 | US20030143233 For use in diagnosis, therapy |
| 07/31/2003 | US20030143232 Incubating survivin and p34cdc2-cyclin B1 kinase complex in presence of an agent; determining whether agent modulates phosphorylation of survivin by p34cdc2-cyclin B1 kinase complex, identifying an agent which modulates phosphorylation |
| 07/31/2003 | US20030143226 For therapy of arteriosclerosis, thrombocytopenia, kidneyd iseases, various types of inflammation such as myocardial ischemic reperfusion injury, inflammatory reactions after percutaneous transluminal coronary recanalization (PTCR)) |
| 07/31/2003 | US20030143216 For therapy of fungal infections; for detecting chitin, binding chitin |
| 07/31/2003 | US20030143192 Chemokine beta-7 |
| 07/31/2003 | US20030143190 For modulating the immune system; therapy of cancer |
| 07/31/2003 | US20030143160 Administering conjugate of the entity and a light-generating moiety; immobilizing the subject within the detection field of a photodetector device; measuring photon emission with photodetectorl; constructing image |
| 07/31/2003 | US20030140818 Aerobic fermentation of Sphingomonas |
| 07/31/2003 | CA2732012A1 Genetic sequences having methyltransferase activity and uses therefor |
| 07/31/2003 | CA2510751A1 Multimers of receptor-binding ligands |
| 07/31/2003 | CA2474623A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 07/31/2003 | CA2474353A1 Method for screening a drug ameliorating insulin resistance |
| 07/31/2003 | CA2474259A1 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | CA2474033A1 Fermentation of pentose sugars |
| 07/31/2003 | CA2473957A1 Species of fungi and their use in pest and disease control |
| 07/31/2003 | CA2473716A1 Alanine 2,3- aminomutase |
| 07/31/2003 | CA2473707A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/31/2003 | CA2473474A1 Alteration of rab38 function to modulate mammalian pigmentation |
| 07/31/2003 | CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 07/31/2003 | CA2472725A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2472723A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2471749A1 Biocidal compounds and their preparation |
| 07/31/2003 | CA2454358A1 Multimeric proteins and methods of making and using same |
| 07/30/2003 | EP1331274A1 Process for producing d-serine |
| 07/30/2003 | EP1331272A1 Novel glucose dehydrogenase and process for producing the dehydrogenase |
| 07/30/2003 | EP1331271A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 07/30/2003 | EP1331269A1 Novel protein, process for producing the same and use thereof |
| 07/30/2003 | EP1331268A1 Novel proteins, genes encoding them and method of using the same |
| 07/30/2003 | EP1331263A1 Drying-resistant yeast |
| 07/30/2003 | EP1331006A1 Dietary supplements comprising growth media |
| 07/30/2003 | EP1330551A2 Affinity maturation by competitive selection |
| 07/30/2003 | EP1330543A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 07/30/2003 | EP1330537A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 07/30/2003 | EP1330535A2 Kini-3 motor protein and methods for its use |
| 07/30/2003 | EP1330528A2 Regulation of human serine-threonine protein kinase |
| 07/30/2003 | EP1330525A2 Nod2 nucleic acids and proteins |
| 07/30/2003 | EP1330522A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330521A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330516A2 Surface transfection and expression procedure |
| 07/30/2003 | EP1330513A1 Recombinant zymomonas mobilis with improved xylose utilization |
| 07/30/2003 | EP1330475A2 Neuromedin u delta polypeptides |
| 07/30/2003 | EP1330473A2 Streptococcal genes |
| 07/30/2003 | EP1330469A2 Glycoproteins and methods of use therefof |
| 07/30/2003 | EP1330264A2 Vaccine for treating allergy |
| 07/30/2003 | EP1330263A2 Method for down-regulating ige |
| 07/30/2003 | EP0941349B1 Methods for producing polypeptides in surfactin mutants of bacillus cells |
| 07/30/2003 | EP0851926B1 Variants of human recombinant interferon-gamma (rhu-ifn-gamma) having increased heat-stability |
| 07/30/2003 | EP0837694B1 Leptospira membrane proteins |
| 07/30/2003 | EP0730652B1 Dna sequences for ammonium transporter, plasmids, bacteria, yeasts, plant cells and plants containing the transporter |
| 07/30/2003 | CN1433474A Regulaed antigen delivery system (RADS) involving bacteria |
| 07/30/2003 | CN1433467A Modified alpha-1, 2-fucosyl transferase gene and process for producing alpha-1, 2-fucosyl transferase and fucose-containing sugar chain |
| 07/30/2003 | CN1433466A MASP-3, complement-fixing enzyme, and uses for it |
| 07/30/2003 | CN1433465A Method for preservation of viruses and mycorplasma |